One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is VIVUS Inc. (VVUS). This Medical – Biomedical/Genetics stock has actually seen loss estimates narrow over the past month for …
VIVUS, Inc. (NASDAQ: VVUS) is not worth recovering the great news for the company ... The company has thousands of shareholders who have owned this stock at prices higher and lower and these shareholders were all made whole last night.
Investors can receive FREE Stock Alerts by visiting doubleinstocks.com at the following link: http://www.doubleinstocks.com Today's alerts include: Zamage Digital Art, Inc. (Other OTC: ZMGD.PK), VIVUS Inc. …
Infinera Corporation (NASDAQ: INFN) 13.5% HIGHER; reported Q4 EPS of $0.13, $0.02 better than the analyst …
Campbell, CA-based VIVUS, Inc. VVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies to address unmet medical needs. The company's portfolio comprises two drugs, Qsymia for …
A month has gone by since the last earnings report for VIVUS, Inc. VVUS. Shares have lost about 19.8% in that time frame, underperforming the market. Will the recent negative trend continue leading up to the stock's next earnings …
Yahoo!5mon
Mr. David York Norton is Independent Chairman of the Board of the Company, since July 19, 2013. From February 2012 until July 2012, Mr. Norton served as Interim CEO of Savient Pharmaceuticals Inc., a pharmaceutical company that filed …
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is VIVUS Inc. (NASDAQ: VVUS). This Medical – Biomedical/Genetics stock has actually seen loss estimates narrow over the past …